{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:41:42Z","timestamp":1740170502817,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s40520-019-01257-9","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:02:41Z","timestamp":1562598161000},"page":"809-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nuclear medical imaging as part of dementia diagnostics in psychiatric day-care clinics and inpatient care settings"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9326-8193","authenticated-orcid":false,"given":"Jonathan","family":"Vogelgsang","sequence":"first","affiliation":[]},{"given":"Bernhard","family":"Kis","sequence":"additional","affiliation":[]},{"given":"Katrin","family":"Radenbach","sequence":"additional","affiliation":[]},{"given":"Claus","family":"Wolff-Menzler","sequence":"additional","affiliation":[]},{"given":"Kiriaki","family":"Mavridou","sequence":"additional","affiliation":[]},{"given":"Charles","family":"Tim\u00e4us","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Gy\u00dfer","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Philipp","family":"Hessmann","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"1257_CR1","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1001\/archinte.163.18.2219","volume":"163","author":"AM Clarfield","year":"2003","unstructured":"Clarfield AM (2003) The decreasing prevalence of reversible dementias. Arch Intern Med 163:2219. https:\/\/doi.org\/10.1001\/archinte.163.18.2219","journal-title":"Arch Intern Med"},{"key":"1257_CR2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/jnnp.73.4.390","volume":"73","author":"A Hejl","year":"2002","unstructured":"Hejl A, H\u00f8gh P, Waldemar G (2002) Potentially reversible conditions in 1000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry 73:390\u2013394","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1257_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/ene.13728","volume":"25","author":"F Nobili","year":"2018","unstructured":"Nobili F, Arbizu J, Bouwman F et al (2018) European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol 25:1201\u20131217. https:\/\/doi.org\/10.1111\/ene.13728","journal-title":"Eur J Neurol"},{"key":"1257_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ageing\/afy004","volume":"47","author":"AJ Bayer","year":"2018","unstructured":"Bayer AJ (2018) The role of biomarkers and imaging in the clinical diagnosis of dementia. Age Ageing 47:641\u2013643. https:\/\/doi.org\/10.1093\/ageing\/afy004","journal-title":"Age Ageing"},{"key":"1257_CR5","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00259-018-4024-1","volume":"45","author":"M Boccardi","year":"2018","unstructured":"Boccardi M, Festari C, Altomare D et al (2018) Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia. Eur J Nucl Med Mol Imaging 45:1470\u20131486. https:\/\/doi.org\/10.1007\/s00259-018-4024-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1257_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000486546","volume":"45","author":"R Knight","year":"2018","unstructured":"Knight R, Khondoker M, Magill N et al (2018) A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord 45:131\u2013151. https:\/\/doi.org\/10.1159\/000486546","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1257_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00115-018-0533-1","volume":"89","author":"M Tscheuschler","year":"2018","unstructured":"Tscheuschler M, Gebest M, Jessen F et al (2018) Bedeutung molekularer Bildgebung (PET) in der Diagnostik von Demenzerkrankungen. Nervenarzt 89:843\u2013856. https:\/\/doi.org\/10.1007\/s00115-018-0533-1","journal-title":"Nervenarzt"},{"key":"1257_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1148\/radiol.2311021620","volume":"231","author":"MB Patwardhan","year":"2004","unstructured":"Patwardhan MB, McCrory DC, Matchar DB et al (2004) Alzheimer disease: operating characteristics of pet\u2014a meta-analysis. Radiology 231:73\u201380. https:\/\/doi.org\/10.1148\/radiol.2311021620","journal-title":"Radiology"},{"key":"1257_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/JAD-2011-110458","volume":"26","author":"LM Bloudek","year":"2011","unstructured":"Bloudek LM, Spackman DE, Blankenburg M et al (2011) Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 26:627\u2013645. https:\/\/doi.org\/10.3233\/JAD-2011-110458","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1257_CR10","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/brain\/awm177","volume":"130","author":"NL Foster","year":"2007","unstructured":"Foster NL, Heidebrink JL, Clark CM et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain 130:2616\u20132635. https:\/\/doi.org\/10.1093\/brain\/awm177","journal-title":"Brain"},{"key":"1257_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305\u2013313. https:\/\/doi.org\/10.1016\/S1474-4422(07)70057-1","journal-title":"Lancet Neurol"},{"key":"1257_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol 11:669\u2013678. https:\/\/doi.org\/10.1016\/S1474-4422(12)70142-4","journal-title":"Lancet Neurol"},{"key":"1257_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13195-017-0290-6","volume":"9","author":"B Michalowsky","year":"2017","unstructured":"Michalowsky B, Flessa S, Hertel J et al (2017) Cost of diagnosing dementia in a German memory clinic. Alzheimers Res Ther 9:65. https:\/\/doi.org\/10.1186\/s13195-017-0290-6","journal-title":"Alzheimers Res Ther"},{"key":"1257_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1055\/s-0042-115846","volume":"44","author":"H Hopf","year":"2017","unstructured":"Hopf H, Diebels E (2017) Characteristics and practice in german psychiatric day-clinics. Psychiatr Prax 44:228\u2013233. https:\/\/doi.org\/10.1055\/s-0042-115846","journal-title":"Psychiatr Prax"},{"key":"1257_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00391-016-1031-3","volume":"50","author":"M Estrella","year":"2017","unstructured":"Estrella M, Roberts A, M\u00e4urer A et al (2017) Akzeptanz der Demenzdiagnostik bei station\u00e4ren, geriatrischen Patienten. Z Gerontol Geriatr 50:52\u201358. https:\/\/doi.org\/10.1007\/s00391-016-1031-3","journal-title":"Z Gerontol Geriatr"},{"key":"1257_CR16","unstructured":"Deuschl G, Maier W S3-Leitlinie \u201eDemenzen\u201c, http:\/\/www.dgn.org\/leitlinien, posted 25 Januar 2016, Accessed 29 November 2017. In: Deuschl G, Maier W S3-leitlin. Demenzen. Dtsch. Gesellschaft f\u00fcr Neurol. Hrsg. Leitlinien f\u00fcr Diagnostik und Ther. der Neurol. http:\/\/tinyurl.com\/hkwk6lf. Accessed 29 Nov 2017"},{"key":"1257_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1136\/jnnp-2014-310090","volume":"86","author":"L Harper","year":"2015","unstructured":"Harper L, Barkhof F, Fox NC et al (2015) Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 86:1225\u20131233. https:\/\/doi.org\/10.1136\/jnnp-2014-310090","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1257_CR18","first-page":"1","volume":"14","author":"SL Bermingham","year":"2014","unstructured":"Bermingham SL (2014) The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis. Ont Health Technol Assess Ser 14:1\u201367","journal-title":"Ont Health Technol Assess Ser"},{"key":"1257_CR19","first-page":"204","volume":"29","author":"D Dormont","year":"2008","unstructured":"Dormont D, Seidenwurm DJ, Expert Panel on Neurologic Imaging, American College of Radiology (2008) Dementia and movement disorders. AJNR Am J Neuroradiol 29:204\u2013206","journal-title":"AJNR Am J Neuroradiol"},{"key":"1257_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"1257_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12149-009-0330-9","volume":"24","author":"A Drzezga","year":"2010","unstructured":"Drzezga A (2010) Amyloid-plaque imaging in early and differential diagnosis of dementia. Ann Nucl Med 24:55\u201366. https:\/\/doi.org\/10.1007\/s12149-009-0330-9","journal-title":"Ann Nucl Med"},{"key":"1257_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00259-011-2045-0","volume":"39","author":"VL Villemagne","year":"2012","unstructured":"Villemagne VL, Klunk WE, Mathis CA et al (2012) A\u03b2 imaging: feasible, pertinent, and vital to progress in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 39:209\u2013219. https:\/\/doi.org\/10.1007\/s00259-011-2045-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1257_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1055\/s-0033-1349505","volume":"41","author":"H Kaduszkiewicz","year":"2013","unstructured":"Kaduszkiewicz H, Wiese B, Steinmann S et al (2013) Diagnosestellung und Diagnosecodierung von Demenzen im Spiegel der Abrechnungsdaten der gesetzlichen Krankenversicherung. Psychiatr Prax 41:319\u2013323. https:\/\/doi.org\/10.1055\/s-0033-1349505","journal-title":"Psychiatr Prax"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01257-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40520-019-01257-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01257-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T15:06:34Z","timestamp":1608649594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40520-019-01257-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1007\/s40520-019-01257-9","relation":{},"ISSN":["1720-8319"],"issn-type":[{"type":"electronic","value":"1720-8319"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no potential conflict of interest to disclose. Stephan Gy\u00dfer is a full-time employee of GSG consultant. Jens Wiltfang is supported by an Il\u00eddio Pinho professorship and iBiMED (UID\/BIM\/04501\/2013), and FCT project PTDC\/DTP_PIC\/5587\/2014 at the University of Aveiro, Portugal. Jens Wiltfang received honoraria for consulting activities, lectures, or advisory board participation from Pfizer, Eli Lilly, Hoffmann-La-Roche, MSD Sharp\u2009+\u2009Dome, Janssen-Cilag GmbH, Immungenetics AG, Boehringer Ingelheim. Jens Wiltfang holds patents EP1270592B1, US 6,849,416 B2, EP2095128B1, and EP3105589A1. Bernhard Kis received honoraria for authorships, publisher activities, advisory board participation and speaker fees from ecomed, Hogrefe, Medicine, Dt. Krankenhausgeselschaft, and Shire. Claus Wolff-Menzler received honoraria for consulting activities from GSG, Vitro GmbH, LVR, Janssen, LWL, Mibeg-Institute, Agfa\/Orbis, DKI, PKM, Asklepios, Alexianer, ID-Schwarz, LivaNova, Servier, ZEB, and DKCT.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Since anonymized data were used, informed consent could not be obtained from the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All data generated or analyzed during this study are included in this published article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}